Recent investigations into Ameano peptides are demonstrating significant clinical potential across a range of diseases . These tiny molecules , derived from biological origins , seem to offer unique approaches for addressing difficult conditions. Notably, early data imply promise in areas such as neurodegenerative conditions, swelling , and even sp